Mindray DS USA, Inc. recalled 2,278 BeneVision N1 Patient Monitors on August 15, 2025. The monitors may activate an abnormal alarm pause, compromising patient safety. Health professionals must cease using these devices immediately and follow recall instructions.
Potential for activation of an abnormal alarm pause.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Mindray DS USA, Inc. dba Mindray North America or your healthcare provider for instructions. Notification method: Letter
The recalled BeneVision N1 Patient Monitors include various part numbers: 6660E-PA00017, 6660E-PA00014, and others. The devices were distributed worldwide, including Canada, and the software versions affected are 1.04.00.01, 1.05.00.01, 1.06.00.01, and 1.06.01.01.
The risk involves the potential for activation of an abnormal alarm pause. This malfunction can lead to serious consequences in patient monitoring.
There have been no specific incident or injury reports associated with this recall as of the report date.
Immediately stop using the device. Follow the recall instructions provided by Mindray and contact your healthcare provider for further guidance.
For more information, contact Mindray DS USA, Inc. at their official website or customer service line.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.